Paramount BioSciences dedicates its own capital to seed portfolio companies through formation, the in-licensing of drug candidates and the initial stages of product development. Additional financing for the portfolio companies may be raised through Paramount BioCapital, Inc. an affiliated broker-dealer and FINRA member firm. For more information about FINRA, see www.finra.org.
 
References to specific portfolio companies are presented to illustrate Paramount BioSciences' experience developing life science companies only and should not be construed as a recommendation of, an offer to sell, or a solicitation of an offer to purchase interests in any particular security or portfolio company. Portfolio companies referred to on this website currently are not available for investment and are not open to new investors. This information is not representative of all portfolio companies or investments of Paramount BioSciences.
 
© 2008 Paramount BioSciences